{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:52:04Z","timestamp":1788313924879,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Post Graduate Institute of Medical Education and Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.imbio.2020.152000","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T11:42:17Z","timestamp":1597146137000},"page":"152000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-complement factor I antibody associated atypical hemolytic uremic syndrome \u2013 A new insight for future perspective!"],"prefix":"10.1016","volume":"225","author":[{"given":"Srinivasavaradan","family":"Govindarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa","family":"Dawman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karalanglin","family":"Tiewsoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imbio.2020.152000_bib0005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00467-019-04233-7","article-title":"Hemolytic uremic syndrome in a developing country: consensus guidelines","volume":"34","author":"Bagga","year":"2019","journal-title":"Pediatr. Nephrol."},{"issue":"October 2","key":"10.1016\/j.imbio.2020.152000_bib0010","article-title":"Haemolytic uremic syndrome in children (1955-2015): a 60 years journey","volume":"1","author":"Bakr","year":"2015","journal-title":"J. Nephrol. Res."},{"issue":"February 2","key":"10.1016\/j.imbio.2020.152000_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"December 12","key":"10.1016\/j.imbio.2020.152000_bib0020","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"June 6","key":"10.1016\/j.imbio.2020.152000_bib0025","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J. Med. Genet."},{"issue":"March 3","key":"10.1016\/j.imbio.2020.152000_bib0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.05750611","article-title":"Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?","volume":"7","author":"Kavanagh","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"April 2","key":"10.1016\/j.imbio.2020.152000_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ckj\/sfx078","article-title":"Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome","volume":"11","author":"Khandelwal","year":"2018","journal-title":"Clin. Kidney J."},{"issue":"September 6","key":"10.1016\/j.imbio.2020.152000_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","author":"Loirat","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"issue":"January 1","key":"10.1016\/j.imbio.2020.152000_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"August 3","key":"10.1016\/j.imbio.2020.152000_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J. Nephrol."},{"issue":"July 2","key":"10.1016\/j.imbio.2020.152000_bib0055","first-page":"101","article-title":"Atypical hemolytic uremic syndrome with diacylglycerol kinase epsilon (DGKE) gene mutation","volume":"2","author":"Sharma","year":"2019","journal-title":"Asian J. Pediatric Nephrol."},{"issue":"March 1","key":"10.1016\/j.imbio.2020.152000_bib0060","first-page":"8","volume":"2","author":"Summary of Recommendation Statements","year":"2012","journal-title":"Kidney Int. Suppl. (2011)"},{"issue":"April 2","key":"10.1016\/j.imbio.2020.152000_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1751-553X.2011.01380.x","article-title":"ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes","volume":"34","author":"Zini","year":"2012","journal-title":"Int. J. Lab. Hematol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520303466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520303466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:46:49Z","timestamp":1759250809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298520303466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0171298520303466"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152000","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-complement factor I antibody associated atypical hemolytic uremic syndrome \u2013 A new insight for future perspective!","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152000"}}